In 1986 human tissue plasminogen activator (tPA, Activase; Genentech, S. San Francisco, CA, USA) became the first therapeutic protein from recombinant mammalian cells to obtain market approval. Today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback